MED Medifast Inc

Price (delayed)

$12.89

Market cap

$144.14M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.69

Enterprise value

$106.46M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 22

® : Medifast is the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTA VIA®, which provides people with a simple, yet comprehensive approach to help ...

Highlights
The company's quick ratio rose by 11% YoY
Medifast's debt has soared by 69% YoY but it has decreased by 25% from the previous quarter
MED's net income has shrunk by 60% QoQ
The EPS has dropped by 58% since the previous quarter

Key stats

What are the main financial stats of MED

MED stock price

How has the Medifast stock price performed over time
Intraday
-1.83%
1 week
1.26%
1 month
10.93%
1 year
10.83%
YTD
20.69%
QTD
11.89%

Financial performance

How have Medifast's revenue and profit performed over time
Revenue
$299.57M
Gross profit
$207.33M
Operating income
-$34.78M
Net income
-$40.85M
Gross margin
69.2%
Net margin
-13.6%
Medifast's operating margin has shrunk by 87% QoQ
The operating income has shrunk by 78% QoQ
Medifast's net margin has plunged by 68% from the previous quarter
MED's net income has shrunk by 60% QoQ

Price vs fundamentals

How does MED's price correlate with its fundamentals

Growth

What is Medifast's growth rate over time

Valuation

What is Medifast stock price valuation
P/E
N/A
P/B
0.8
P/S
0.48
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.36
The EPS has dropped by 58% since the previous quarter
MED's P/B is 80% below its 5-year quarterly average of 4.1 but 35% above its last 4 quarters average of 0.6
The equity has contracted by 16% YoY and by 8% from the previous quarter
MED's revenue is down by 30% year-on-year and by 5% since the previous quarter
The P/S is 23% higher than the last 4 quarters average of 0.4 but 18% lower than the 5-year quarterly average of 0.6

Efficiency

How efficient is Medifast business performance
The return on sales has dropped by 120% since the previous quarter
The return on invested capital has dropped by 99% since the previous quarter
MED's ROE has shrunk by 66% QoQ
The ROA has plunged by 63% from the previous quarter

Dividends

What is MED's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Medifast financials performed over time
The company's quick ratio rose by 11% YoY
Medifast's total liabilities has increased by 11% YoY but it has decreased by 7% QoQ
Medifast's debt is 89% less than its equity
Medifast's debt to equity has soared by 83% YoY but it has decreased by 21% from the previous quarter
Medifast's debt has soared by 69% YoY but it has decreased by 25% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.